According to Agenus 's latest financial reports the company's total debt is $87.34 M. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2022-12-31 | $78.42 M | 34.55% |
2021-12-31 | $58.28 M | 4.59% |
2020-12-31 | $55.72 M | 138.22% |
2019-12-31 | $23.39 M | 75.13% |
2018-12-31 | $13.35 M | -91.81% |
2017-12-31 | $0.16 B | 24.74% |
2016-12-31 | $0.13 B | 14.17% |
2015-12-31 | $0.11 B | 1799.47% |
2014-12-31 | $6.02 M | -32.03% |
2013-12-31 | $8.86 M | -75.32% |
2012-12-31 | $35.91 M | 9.09% |
2011-12-31 | $32.92 M | -3.72% |
2010-12-31 | $34.19 M | -31.11% |
2009-12-31 | $49.64 M | -26.98% |
2008-12-31 | $67.98 M | -12.33% |
2007-12-31 | $77.54 M | 2.74% |
2006-12-31 | $75.47 M | 1710.17% |
2005-12-31 | $4.16 M | -57.97% |
2004-12-31 | $9.92 M | -37.47% |
2003-12-31 | $15.86 M | 2780.4% |
2002-12-31 | $0.55 M | -90.96% |
2001-12-31 | $6.09 M |
Company | Total debt | differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $52.90 B | 60,471.06% | ๐บ๐ธ USA |
![]() Merck MRK | $30.74 B | 35,099.84% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | $39.18 B | 44,762.45% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | $27.08 B | 30,912.74% | ๐ฌ๐ง UK |
![]() Celldex Therapeutics CLDX | $3.25 M | -96.27% | ๐บ๐ธ USA |